Hydantoin derivatives

Details Hydantoin derivatives Hydantoin derivatives

1979-06-13

1980-11-25

Brust, Joseph Paul

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

546 18, 424256, C07D47110, A61K 3147

Patent

active

042359112

ABSTRACT:
A series of novel tetrahydroquinoline-derived spiro-hydantoin compounds has been prepared, including their pharmaceutically acceptable acid addition salts. These particular compounds are useful in therapy as aldose reductase inhibitors for the control of certain chronic diabetic complications. Preferred member compounds include 1'-methyl-1',2',3',4'-tetrahydro- spiro-[imidazolidine-4,4'-quinoline]-2,5-dione, 6'-chloro-1',2',3',4'-tetrahydro-spiro-[imidazolidine-4,4'-quinoline]-2,5- dione, 7'-chloro-1',2',3',4'-tetrahydro-spiro-[imidazolidine-4,4'-quinoline]-2,5- dione and 1'-methyl-1',2',3',4'-tetrahydro-spiro-[imidazolidine-4,4'-pyrido(2,3-b)py ridine]-2,5-dione. Methods for preparing these compounds from known starting materials are provided.

REFERENCES:
patent: 3821383 (1974-06-01), Sestanj et al.
Faust, et al., J. American Pharm. Assoc., 46, (1957), pp. 118-124.

Affiliated with

Also associated with

Rating

Hydantoin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydantoin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1129906